Waltham, MA - Digoxin use is linked to mortality in patients with end-stage renal disease (ESRD), according to the results of a retrospective cohort study reported online June 24, 2010 in the Journal ...
Digoxin is commonly used in patients with heart failure and atrial fibrillation and is the oldest drug in cardiovascular medicine 1. In 1997, the Digitalis Investigation Group (DIG) trial, a large ...
Myocardial ischemia–reperfusion injury (MIRI) induces life-threatening damages to the cardiac tissue, and pharmacological means to achieve cardioprotection are sorely needed. MIRI severity varies ...
Findings from the current study demonstrate that over half of chronic HF patients in the DIG trial had severe and more advanced disease as evidenced by the presence of NYHA III–IV symptoms, LVEF <25%, ...
"In the DIG trial, published in 1997, digoxin had a neutral effect on the primary endpoint of mortality, but a 28% reduction in heart failure hospitalizations (a secondary endpoint) was observed.
Digoxin is a medication used to help treat heart failure and heartbeat irregularities. Your digoxin levels tell you the amount of digoxin that is in your body at a certain time. Having too much or too ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results